Panel 3: phase III investigations.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D010349:Patient Compliance; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration